Economy

Nabriva Therapeutics AG's (NBRV) "Overweight" Rating Reaffirmed at Cantor Fitzgerald

Nabriva Therapeutics AG's (NBRV)

Nabriva Therapeutics plc - Ordi shares had a trading volume of 209K by the end of trading on Friday. The stock has an average rating of Buy and an average target price of $16.25.

Investors are feeling more bearish of late as indicated by the motion in short interest. The stock had a rise in short interest of 3.44% between July 31, 2017 and August 15, 2017. Specifically, the ECR rates were 87.3% for lefamulin and 90.2% for moxifloxacin with/without linezolid.

Additionally, here are a few investment firms who have increased or decreased their stake in (NBRV). The total value of its holdings decreased 12.7%. Royal Bank of Canada now owns 52,807 shares of the biotechnology company's stock valued at $553,000 after buying an additional 8,650 shares during the last quarter. Morgan Stanley owns 3,584 shares valued at $43,000. The total value of its holdings increased 500.0%.

As of the end of the quarter Tower Research Capital LLC (trc) had acquired 409 shares growing its stake by 435.1%. Tower Research Capital LLC (trc) now controls 503 shares valued at $6,000. Acuta Capital Partners, LLC reduced its investment by selling 28,673 shares a decrease of 4.1% from 12/31/2016 to 03/31/2017. Acuta Capital Partners LLC now owns 706,383 shares of the company's stock valued at $4,210,000 after buying an additional 122,862 shares in the last quarter. The value of the position overall is up by 93.2%. Zacks Investment Research raised Nabriva Therapeutics AG from a hold rating to a buy rating and set a $11.00 price objective for the company in a report on Saturday, May 27th. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the company.

The company will host a conference call this morning at 8:30 am ET to discuss the results.

Shares last traded at $7.40 significantly below the 50 day moving average of $9.21 and much lower than the 200 day moving average of $10.28. The 50 day moving average was down $-1.81 or -19.65% whereas the 200 day average was down by -27.99%. The biotechnology company reported ($0.54) EPS for the quarter, topping the Zacks' consensus estimate of ($5.83) by $5.29.

Nabriva Therapeutics AG is an Austria-based clinical-stage biopharmaceutical company engaged in the research and development of antibiotics to treat infections. I am extremely proud and appreciative of the Nabriva Therapeutics team that has advanced lefamulin, which has the potential to be the first in a new class of antibiotics for CABP in more than 15 years, from initial discovery in our labs to this important milestone. This is the first of two phase 3 clinical trials needed to seek regulatory approval for lefamulin. The Company develops both intravenous (IV) and oral formulations of lefamulin for the treatment of community-acquired bacterial pneumonia (CABP). It is also developing BC-7013, a topical pleuromutilin product candidate, which has completed a Phase 1 clinical trial. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics AG in 2007.



Like this

loading...
loading...

Latest


18 September 2017
American Electric Power (AEP) Earns News Sentiment Score of 0.25
Point72 Asia Hong Kong Ltd purchased a new stake in shares of American Electric Power during the 1st quarter worth about $105,000. BidaskClub raised American Electric Power from a "hold" rating to a "buy" rating in a research note on Tuesday, August 22nd.

18 September 2017
Malware discovered in CCleaner put millions of users at risk
CCleaner Cloud 1.07.3191 was released on August 24th, 2017, and a non-compromised version of the program on September 15th, 2017. The nature of the attack code suggests that the hacker won access to a machine used to create CCleaner, Williams said .

18 September 2017
Career Education Corporation (NASDAQ:CECO) Trading Volume Significantly Higher
Arizona State Retirement System bolstered its investment by buying 200 shares an increase of 0.6% from 03/31/2017 to 06/30/2017. Career Education Corporation has a 12 month low of $6.39 and a 12 month high of $12.59. "(CECE) Now?" on August 25, 2017.

18 September 2017
Viacom Inc. (VIAB) Receives Consensus Rating of "Hold" from Analysts
The company reported $1.17 earnings per share for the quarter, beating the Thomson Reuters' consensus estimate of $1.05 by $0.12. Johnson Financial Group Inc. acquired a new stake in Viacom during the second quarter worth approximately $108,000.

18 September 2017
Delhi Police arrest suspected al-Qaeda operative
Ahmed was arrested by Delhi Police's special cell and was later handed over to the West Bengal police. Meanwhile, Haq is now undergoing interrogation and more details regarding his arrest are awaited.

18 September 2017
I am not a traitor, says whistleblower Chelsea Manning
Tom Scott, who co-founded The Nantucket Project with Kate Brosnan, said they invited Manning for "clarity of understanding". Manning was convicted in 2013 of leaking a trove of classified documents.

18 September 2017
Indian Railways cuts down sleeping hours in train
Till now, the existing time for sleeping for the passengers in the reserved coaches was between 9 pm to 6 am, as reported by PTI . However, there was an exception for a certain set of passengers like the disabled, pregnant ladies, and passengers who are sick.

18 September 2017
Tenet Healthcare Corporation (THC) Shares Sold by SG Americas Securities LLC
Denbury Resources Inc. (NYSE:DNR) share price increased in the last trading session with a previous 52-week high of $4.29. Therefore 0 are positive. ( THC ) has a market cap of $1.77 billion and over the last 12 months, Tenet Healthcare Corp .

18 September 2017
Agnico Eagle Mines' (AEM) Hold Rating Reiterated at TD Securities, Report finds
A month ago, they told us to expect earnings of US$0.15 per share while three months ago their EPS consensus estimate was US$0.17. Analysts await Amphenol Corporation (NYSE:APH) to report earnings on October, 18. (NASDAQ:DORM) for 124,430 shares.

18 September 2017
Saudi coalition airstrikes kills 12 civilians
He gave no further details and there has been no indication by the UAE of any missiles landing on their territory. In both instances, the missiles were shot down by Saudi Air Defenses Forces before they could cause any damage.